IBRX
ImmunityBio (IBRX) Investor Questions
Review ImmunityBio (IBRX) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- ImmunityBio
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 50
- Annual revenue
- $113.29M
- Annual net income
- $-351.40M
- Annual free cash flow
- $-308.78M
ImmunityBio (IBRX) Investor Questions research
ImmunityBio trades under the ticker IBRX. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review IBRX through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.